TWD
RARE icon

True Wealth Design’s Ultragenyx Pharmaceutical RARE Stock Holding History

True Wealth Design’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.8K Buy
744
+241
+48% +$5.99K 0.01% 736
2026
Q1 		$10.5K Buy
+503
New +$11.3K ﹤0.01% 953
2025
Q2 		– Sell
-5
Closed -$182 – 2778
2025
Q1 		$182 Buy
+5
New +$208 ﹤0.01% 1993
2024
Q4 		– Sell
-778
Closed -$43.2K – 1488
2024
Q3 		$43.2K Buy
+778
New +$39.6K 0.02% 164

Other funds holding RARE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

True Wealth Design's RARE Position: Q2 2026 in Review

True Wealth Design increased its Ultragenyx Pharmaceutical (RARE) stake by 48% in Q2 2026, buying an estimated $5.99K and bringing the position to 744 shares worth $24.8K. The position accounts for 0.01% of the portfolio, ranked #736.

True Wealth Design first reported a position in RARE in Q3 2024 and has held it in 4 quarters since. The position peaked at $43.2K in Q3 2024. 310 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

  • True Wealth Design held 744 shares of Ultragenyx Pharmaceutical worth $24.8K as of Q2 2026.
  • True Wealth Design bought 241 Ultragenyx Pharmaceutical shares in Q2 2026, an estimated $5.99K.
  • Ultragenyx Pharmaceutical made up 0.01% of True Wealth Design's portfolio in Q2 2026, its #736 holding.
  • True Wealth Design first reported a position in Ultragenyx Pharmaceutical in Q3 2024 and has held it in 4 quarters since.
  • True Wealth Design's Ultragenyx Pharmaceutical position peaked at $43.2K in Q3 2024.
  • 310 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.